Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...
The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled ...
Kennedy Jr., President-elect Donald Trump’s choice to lead the nation’s health agencies, formally asked the Food and Drug ...
Moderna , Inc. (NASDAQ:MRNA) today confirmed that it has won a tender to supply its mRNA COVID-19 vaccine in the European Union (EU), Norway, and North Macedonia. The agreement, valid for up to four ...
Moderna (MRNA) stock gained in the premarket after the company received a tender to supply its COVID-19 vaccine in the EU, ...
Through the first nine months of 2024, Moderna's revenue of $2.3 billion represents ... underscoring the company's continued dependence on its COVID-19 shot, commercialized as Spikevax.
1, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals six months of age and older. Moderna is a leader in the creation of the field of mRNA medicine. Through the ...